Inactive

THIS IS NOT A SOLICITATION ANNOUNCEMENT - This is a Sources Sought Notice and is issued solely for information and planning purposes - it does not constitute a Request for Quote (RFQ) or a promise to ... THIS IS NOT A SOLICITATION ANNOUNCEMENT - This is a Sources Sought Notice and is issued solely for information and planning purposes - it does not constitute a Request for Quote (RFQ) or a promise to issue an RFQ in the future. Solicitations are not available at this time and requests for a solicitation will not receive a response. This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever. All information submitted in response to this announcement is voluntary; the United States Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the United States Government. Not responding to this Sources Sought Notice does not preclude participation in any future RFQ, should one be issued. It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement. The Government will use responses to this notice in formulating its acquisition strategy. If the Government does not receive sufficient information in response to this notice to verify the potential for competition exists, it is possible that a sole-source contract, supported by a Justification and Approval document, will be issued to support the Government's requirement. MRCO-W is seeking the following information (please answer paragraph below with your response): 1. Company name, UEI number, CAGE code, and point of contact information (including phone number and email address), and socioeconomic category(ies) as related to NAICS 325412 (Pharmaceutical Preparation Manufacturing), such as 8(a), HUBZone, Women Owned, Service-Disabled Veteran-Owned, Small, or Other than Small. 2. Capability Statement (limited to ten pages), describing how your company meets the below objectives, providing additional proof where appropriate: 3. The contractor shall provide Healon Pro Ophthalmic Viscoelastic Device (OVD) 10MG/ML 0.85ML. Estimated quantity 900 each per year. Healon Pro (OVD) is a Surgical aid in cataract extraction (intra-and extracapsular), IOL implantation, corneal transplant, glaucoma filtration and retinal attachment surgery. Healon Pro (ODV) provides posterior chamber maintenance for easy maneuverability as well as reliable protection for the eye’s delicate structures during surgery to support Brooke Army Medical Center. It can also be used to efficiently maneuver, separate and control ocular tissues during surgery to support Brooke Army Medical Center.